Shanghai Hajime Advanced Material Technology Co., Ltd.

SZSE:301000 Rapport sur les actions

Capitalisation boursière : CN¥3.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Shanghai Hajime Advanced Material Technology Bilan de santé

Santé financière contrôle des critères 6/6

Shanghai Hajime Advanced Material Technology has a total shareholder equity of CN¥1.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥175.6M respectively. Shanghai Hajime Advanced Material Technology's EBIT is CN¥112.2M making its interest coverage ratio -4.9. It has cash and short-term investments of CN¥594.7M.

Informations clés

0%

Ratio d'endettement

CN¥0

Dette

Ratio de couverture des intérêts-4.9x
Argent liquideCN¥594.72m
Fonds propresCN¥1.18b
Total du passifCN¥175.58m
Total des actifsCN¥1.36b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Shanghai Hajime Advanced Material Technology (SZSE:301000) May Have Issues Allocating Its Capital

Jul 04
Shanghai Hajime Advanced Material Technology (SZSE:301000) May Have Issues Allocating Its Capital

Shanghai Hajime Advanced Material Technology (SZSE:301000) Could Be Struggling To Allocate Capital

Feb 27
Shanghai Hajime Advanced Material Technology (SZSE:301000) Could Be Struggling To Allocate Capital

Analyse de la situation financière

Passif à court terme: 301000's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥163.9M).

Passif à long terme: 301000's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥11.7M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 301000 is debt free.

Réduire la dette: 301000 has no debt compared to 5 years ago when its debt to equity ratio was 6.3%.

Couverture de la dette: 301000 has no debt, therefore it does not need to be covered by operating cash flow.

Couverture des intérêts: 301000 has no debt, therefore coverage of interest payments is not a concern.


Bilan


Découvrir des entreprises saines